Steven J. Younes - Jul 29, 2022 Form 4 Insider Report for Lamb Weston Holdings, Inc. (LW)

Role
CHIEF HUMAN RESOURCES OFFICER
Signature
/s/ Eryk J. Spytek, Attorney-in-Fact
Stock symbol
LW
Transactions as of
Jul 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 05:39 PM
Previous filing
Jul 22, 2022
Next filing
Jul 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LW Common Stock Award $0 +3.01K +37.56% $0.00 11K Jul 29, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LW Employee Stock Option (Right to Buy) Award $0 +23.2K $0.00 23.2K Jul 29, 2022 Common Stock 23.2K $79.66 Direct F2
transaction LW Performance Shares Award $0 +6.56K $0.00 6.56K Jul 29, 2022 Common Stock 6.56K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") that vest 33%, 33% and 34%, respectively, on each of the first three anniversaries of the date of grant,or earlier upon certain events. Each RSU represents a contingent right to receive one share of Lamb Weston Holdings, Inc. common stock upon settlement.
F2 The stock options will become exercisable as to 33%, 33% and 34%, respectively, on each of the first three anniversaries of the date of grant.
F3 Represents a performance share award that may be earned based on the increase in Lamb Weston Holding, Inc.'s stock price from the date of grant to the end of a three-year performance period ending May 25, 2025 above certain targeted levels. Each performance share represents a contingent right to receive one share of Lamb Weston Holdings, Inc. common stock upon settlement. The performance shares are shown at the target level, and the actual amount earned after completion of the performance period may range from 0% (for stock price appreciation of less than 25%) to 100% of the target level (for stock price appreciation equal to 50%) and up to 300% of the target level (for stock price appreciation equal to or greater than 75%), subject to an overall payment value limit equal to eight times the grant value of the award.